InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Beyer Russell P, 首席财务官. Insider active across 1 company, notably SAB Biotherapeutics, Inc.. Aggregated, 1 disclosures have been logged. Activity tracked since 18 October 2021. The latest transaction was disclosed on 18 October 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Russell P. Beyer is the Chief Financial Officer at SAB Biotherapeutics, Inc. He oversees the financial operations of the company, including budgeting and financial reporting. His role is essential in ensuring the financial health and growth of SAB Biotherapeutics.